Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...

We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...

Freakonomics at 20: why AI makes better questions, sharper incentives, and disciplined curiosity the new leadership edge.

At Baylor Genetics, we believe the biggest leap forward for rare disease diagnosis will happen when WGS becomes the standard ...

Roche has introduced its Axelios 1 platform, a next-generation sequencing system that is available for research use and powered by its SBX technology.

Roche debuts Axelios, a gene sequencer targeting academic and research facilities, to compete with Illumina's dominance in ...

Roche Holding AG is looking to take a share of Illumina Inc.’s dominance in the gene sequencing market with the launch of Axelios 1, its next-generation sequencing (NGS) platform designed for accuracy ...

According to MarketsandMarkets, the Epigenetics Market is projected to grow from about USD 2.22 billion in 2026 to USD 3.92 billion by 2031 ...

According to MarketsandMarkets™, the Epigenetics Market is projected to grow from about USD 2.22 billion in 2026 to USD 3.92 ...

AI‑guided analysis surfaces a new CAR T target with multi‑cancer activity, as Penn researchers validate GPNMB‑directed CAR T cells in preclinical models.

AXT's InP substrate revenue surged, order backlog hit $100M+, and margins improved. Find out why I maintain a Hold rating for ...

A team of scientists from the Barbara Ann Karmanos Cancer Institute, Wayne State University and institutions across the U.S.